Literature DB >> 3014720

Insertion and deletion mutants of vaccinia virus.

M E Perkus, D Panicali, S Mercer, E Paoletti.   

Abstract

Thirteen viable insertion mutants of vaccinia virus have been constructed. These mutants, containing coding sequences of the herpes simplex virus thymidine kinase (HSV-TK) gene, were generated by marker transfer via in vivo recombination. The mutants were identified using a replica filter plating technique by in situ hybridization using 32P-nick translated HSV-TK sequences and obtained as pure cultures by repeated plaque purification. Some of these insertion mutants were in turn used as substrates to generate viable deletion mutants of vaccinia virus in the presence of 5'-bromodeoxyuridine. An example of this approach resulting in a vaccinia virus deleted of approximately 1.5 kb of nonessential DNA is presented. Furthermore, the analysis of spontaneously occurring viable deletion mutants of vaccinia lacking approximately 21.4 kb of nonessential DNA is described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014720     DOI: 10.1016/0042-6822(86)90132-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Antibodies directed against a synthetic peptide enable detection of a protein encoded by a vaccinia virus host range gene that is conserved within the Orthopoxvirus genus.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

2.  Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants.

Authors:  M Slabaugh; N Roseman; R Davis; C Mathews
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence.

Authors:  D C Bloom; K M Edwards; C Hager; R W Moyer
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

6.  Partial deletion of the human host range gene in the attenuated vaccinia virus MVA.

Authors:  W Altenburger; C P Süter; J Altenburger
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.

Authors:  P X Guo; S Goebel; M E Perkus; J Taylor; E Norton; G Allen; B Languet; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells.

Authors:  L Kutinová; S Nĕmecková; E Hamsíková; H Závadová; V Ludvíková; J Broucek; D Kunke; J König; L G Zakharova; G V Pashvykina
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 10.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.